Another clinical report with a sample size of 11 individuals showed that dietary 3,000 mg GlcN, which was double the dose used in this trial, showed a trend towards reducing constipation with no significant increase in distinctive genera [ 12 ].
← all excerpts
Effects of D-Glucosamine on the Growth of Human Gut-Dominant Microbiota <i>in vitro</i> and Bowel Movements in Healthy Individuals.
1
—
—